Authors: Tanwiwat Jaikuna1, Marianne Aznar1, Peter Hoskin1, Marcel Van Herk1, Catharine M L West1, Azria David2, Sara Gutiérrez-Enríquez3, Tiziana Rancati4, Barry S Rosenstein5, Dirk de Ruysscher6,7, Elena Sperk8, Paul Symonds9, Christopher J Talbot9, Maria Carmen De Santis10, Ana Vega11, Adam Webb12, Jenny Chang-Claude13, Petra Seibold14, Zoe Lingard1, Eliana Vasquez Osorio1
1The University of Manchester, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Christie NHS Foundation Trust Hospital, Manchester, United Kingdom; 2Université Montpellier, Department of Radiation Oncology, Montpellier Cancer Institute, Inserm, France; 3Vall d'Hebron Institute of Oncology, Hereditary Cancer Genetics Group, Barcelona, Spain; 4Fondazione IRCCS Istituto Nazionale dei Tumori, Prostate Cancer Program, Milan, Italy; 5Icahn School of Medicine at Mount Sinai, Department of Radiation Oncology, Department of Genetics and Genomic Sciences, New York, USA; 6Maastricht University Medical Center, Department of Radiation Oncology (Maastro Clinic), GROW School for Oncology and Developmental Biology, Maastricht, The Netherlands; 7KU Leuven, Radiation Oncology, Leuven, Belgium; 8University of Heidelberg, Department of Radiation Oncology, Universitätsklinikum Mannheim, Medical Faculty Mannheim, Mannheim, Germany; 9University of Leicester, Leicester Cancer Research Centre, Leicester, United Kingdom; 10Fondazione IRCCS Isituto Nazionale dei Tumori, Radiation Oncology 1, Milan, Italy; 11Instituto de Investigación Sanitaria de Santiago de Compostela, Fundación Pública Galega de Medicina Xenómica, Grupo de Medicina Xenómica (USC), Biomedical Network on Rare Diseases (CIBERER), Santiago de Compostela, Spain; 12University of Leicester, Department of Genetics and Genome Biology, Leicester, United Kingdom; 13University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 14German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany